InvestorsHub Logo

flipper44

12/20/21 5:31 PM

#428132 RE: Lykiri #428128

Excellent Lykiri.

Can the rest of us take a break and allow the Lykiri autopilot responder to handle the message board through January 1?

dude409

12/20/21 5:42 PM

#428142 RE: Lykiri #428128

Lykiri, thanks for all you do keeping us informed.
HO-Ho-Ho, and a Partridge in a pear tree.
GLTA

hope4patients

12/20/21 6:03 PM

#428160 RE: Lykiri #428128

Incredibly good post. Lykiri, thank you for the due diligence you share with us, which is always based on FACT. Today is a VERY good day :)

FeMike

12/20/21 6:11 PM

#428170 RE: Lykiri #428128

It is a certification specifically to produce DCVax products.



Please provide me a link showing that this is specifically and only for the production of DCVax products.

dennisdave

12/21/21 10:16 AM

#428432 RE: Lykiri #428128

The MHRA license approval enables the manufacturing of DCVax-L products to get under way at the Sawston facility in addition to continuing at the smaller GMP facility in London. The license also permits the import and GMP manufacture of other cell therapy products under the UK's supply of unlicensed medicinal products ('Specials') regime and for clinical trials under the Investigational Medicinal Products (IMP) Programme.